CIK: 1303782 - Address: C/O Nrx Pharmaceuticals Inc, 1201 N. Market Street, Suite 111, Wilmington, DE 19801
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1110-4-37-63-67-56-45
S%wins100100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/24/23 12:14
8/23/23
NRXPNrx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsJavitt Jonathan CDEDOTChief ScP330.33000100114,768D
8/23/23 09:24
8/22/23
NRXPNrx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsJavitt Jonathan CDEDOTChief ScP640.32200200114,668D
12/9/22 16:33
12/7/22
NRXPNrx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsJavitt Jonathan CDEDTS-4001.000-400-314,468I
6/2/22 09:46
6/1/22
NRXPNrx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsJavitt Jonathan CDEDOTChief ScP.a580.58000100114,868D
6/2/22 08:55
6/1/22
NRXPNrx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsJavitt Jonathan CDEDOTChief ScP5,80058.000100114,868D
8/28/08 16:58
8/27/08
BCLIBrainstorm Cell Therapeutics IncHealthBioPrdBiological Products, (No DiagJavitt Jonathan CNYDS.d-100.25000-40-4960D-16-69-45-25174440-4-37-63-67-56
7/5/05 19:28
6/17/05
QSIIQuality Systems IncCATechSoftwComputer Integrated Systems DJavitt Jonathan CCADM19649.05334988D2561076511-15-112-301431446056

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact